Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
The Lancet. Oncology|December 2, 2019
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective studySheri L Spunt, Lynn Million, Yueh-Yun Chi, et al.Pediatric Blood & Cancer|November 6, 2024
The accuracy of estimating equations for the evaluation of kidney function in adult survivors of unilateral, nonmetastatic, non-syndromic Wilms tumor: A pilot study from the St. Jude Lifetime Cohort StudyDaniel M Green, Mingjuan Wang, Matthew J Krasin, et al.Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.Pediatric Blood & Cancer|July 25, 2020
Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort StudyDaniel M Green, Mingjuan Wang, Matthew J Krasin, et al.Annals of the American Thoracic Society|July 9, 2016
Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE)Daniel M Green, Liang Zhu, Mingjuan Wang, et al.International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology GroupLynn Million, Andrea Hayes-Jordan, Yueh-Yun Chi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.Cancer Discovery|September 30, 2018
Genome-Informed Targeted Therapy for OsteosarcomaLeanne C Sayles, Marcus R Breese, Amanda L Koehne, et al.Cold Spring Harbor Molecular Case Studies|October 25, 2019
Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumorLauren M Sanders, Arun Rangaswami, Isabel Bjork, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupDouglas S Hawkins, Yueh-Yun Chi, James R Anderson, et al.Pageof 17